Serum microRNAs improving the diagnostic accuracy in lung cancer presenting with pulmonary nodules
Author(s) -
Yayi He,
Shengxiang Ren,
Yan Wang,
Xuefei Li,
Caicun Zhou,
Fred R. Hirsch
Publication year - 2018
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2018.07.138
Subject(s) - medicine , lung cancer , lung , adenocarcinoma , nodule (geology) , radiology , microrna , computed tomography , pathology , cancer , gene , biology , paleontology , biochemistry
MicroRNA (miRNA) is an approach for early diagnosing of cancer. We validated a panel of miRNAs (hsa-miR-199a-3p, hsa-miR-148a-3p, hsa-miR-210-3p, hsa-miR-378d and hsa-miR-138-5p) to aid early diagnosis of lung adenocarcinoma by blood test in lung cancer presenting with pulmonary nodules.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom